3,148 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Bought by FORA Capital LLC

FORA Capital LLC acquired a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,148 shares of the medical instruments supplier's stock, valued at approximately $488,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Deutsche Bank AG boosted its holdings in shares of ICU Medical by 41.1% in the fourth quarter. Deutsche Bank AG now owns 21,792 shares of the medical instruments supplier's stock valued at $3,381,000 after buying an additional 6,345 shares during the period. Algert Global LLC lifted its position in ICU Medical by 16.9% during the fourth quarter. Algert Global LLC now owns 6,370 shares of the medical instruments supplier's stock worth $988,000 after acquiring an additional 920 shares during the last quarter. Freestone Grove Partners LP bought a new stake in shares of ICU Medical in the fourth quarter valued at about $368,000. Northern Trust Corp increased its stake in ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after acquiring an additional 40,187 shares during the period. Finally, Quarry LP lifted its holdings in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after acquiring an additional 214 shares during the period. 96.10% of the stock is owned by institutional investors.

ICU Medical Stock Down 0.5%

Shares of ICUI traded down $0.75 during trading hours on Tuesday, hitting $143.59. The company had a trading volume of 224,255 shares, compared to its average volume of 275,107. The stock has a market capitalization of $3.53 billion, a price-to-earnings ratio of -31.42 and a beta of 0.87. The firm has a fifty day moving average price of $140.68 and a 200-day moving average price of $154.77. ICU Medical, Inc. has a 52-week low of $100.91 and a 52-week high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.49. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The business had revenue of $599.49 million during the quarter, compared to analysts' expectations of $574.15 million. During the same period in the previous year, the company earned $0.96 earnings per share. The business's revenue for the quarter was up 6.7% compared to the same quarter last year. On average, equities research analysts forecast that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ICUI has been the subject of several recent analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a report on Saturday. KeyCorp reduced their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Raymond James dropped their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, ICU Medical currently has an average rating of "Moderate Buy" and an average price target of $192.67.

Insider Buying and Selling at ICU Medical

In other news, Director David C. Greenberg sold 1,942 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $143.66, for a total transaction of $278,987.72. Following the transaction, the director now directly owns 6,760 shares of the company's stock, valued at $971,141.60. This represents a 22.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.50% of the company's stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.